In progress
Treatment of Breakthrough and Prevention of Refractory Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients: 2022 Clinical Practice Guideline Update
Overview
Scope: Treatment of breakthrough and prevention of refractory chemotherapy-induced nausea and vomiting in pediatric patients with cancer.
Methods: An international and multidisciplinary panel used the GRADE approach to develop recommendations based on the results of systematic reviews of the literature.